Pfizer acquires Metsera for $10B in obesity drug deal
Pfizer secures Metsera in a $10 billion acquisition, outbidding Novo Nordisk. The deal strengthens Pfizer's position in the booming obesity treatment market. Read more about this pharmaceutical showdown!